DOJ clears U.S. drug companies to distribute hydroxychloroquine to coronavirus patients
The U.S. Department of Justice on Monday cited “extreme urgency” in clearing U.S. pharmaceutical distributors from legal hurdles in order to provide the controversial anti-malaria